Tarun Shah

• 
  www.mpglobal.com/members/teambios.html - [Cached Version]
  Published on: 4/25/2007    Last Visited: 4/25/2007  

  Tarun Shah, MBA, leads Mehta Partners' India based-team that works closely with the home office in New York.He has significantly influenced the evolution of M&A activities in the pharmaceutical industry in recent years, having actively contributed to some of the largest cross-border transactions as the major companies in India accelerate their efforts to globalize.Prior to joining Mehta Partners in 1995, he managed Transpek Finance, a financial services company.Tarun holds his MBA from the M.S. University, Vadodara.Tarun also held Vadodara Stock Exchange membership.
  ...
  Chirag Talati, MBA, covers Indian Pharma along with Tarun Shah & Ashish Patel.

• 
  www.mpglobal.com/members/teamtxt.html - [Cached Version]
  Published on: 4/25/2007    Last Visited: 4/25/2007  

  Tarun Shah, MBA

• 
  www.mpglobal.com/mehta/meet/text/javascript - [Cached Version]
  Published on: 1/31/2008    Last Visited: 2/4/2008  

  Tarun ShahTarun Shah, MBA, MP Advisors, leads Mehta Partners' India-based team that works closely with the home office in New York.He has significantly influenced the evolution of M&A activities in the pharmaceutical industry in recent years, having actively contributed to some of the largest cross-border transactions as the major companies in India accelerate their efforts to globalize.Tarun has also advised many Western companies in their efforts to source custom synthesized materials and perform clinical trials in low-cost/high-skilled countries.

• 
  Drug bust - [Cached Version]
  Published on: 12/23/2005    Last Visited: 12/23/2005  

  Ranbaxy losing the Lipitor case in Delaware will have a dampening effect on all India's generic drug makers, said Tarun Shah, an analyst with the pharmaceutical research firm Mehta Partners, based in New York.

• 
  Foot.com The Foot Health Network - [Cached Version]
  Published on: 12/22/2005    Last Visited: 12/27/2005  

  Losing the Lipitor case will have a dampening effect on all India's generic drug makers, said Tarun Shah, an analyst with the pharmaceutical research firm Mehta Partners, based in New York, "as companies realize, there is no more a jackpot at the end of this."
  ...
  Ranbaxy is shifting resources to other markets like the European Union and Japan to increase growth, but Shah, the analyst, says this will not be enough to please the stock market.

• 
  Indian drug firms to continue with strategy - Business... - [Cached Version]
  Published on: 12/19/2005    Last Visited: 12/20/2005  

  Ranbaxy is shifting resources to other markets like the European Union and Japan to increase growth but this will not be enough to please the market, said Tarun Shah, an analyst with the New York-based pharmaceutical research firm Mehta Partners."The Street will have to accept the harsh reality that the U.S. market cannot remain as lucrative as in the past," he said.

• 
  Meet the Team | Mehta Partners LLC - [Cached Version]
  Published on: 7/29/2008    Last Visited: 7/29/2008  

  Tarun ShahTarun Shah, MBA, MP Advisors, is founder of MP Advisors.Tarun Shah brings 22 years of global experience in Corporate Finance and Investment Banking.He significantly influenced the evolution of cross border M&A activities in the pharmaceutical industry in recent years, having conceptualized some of the important transactions as the major companies across the world accelerate their efforts to create new business models in synchronization with the changing times.Tarun has spotted novel investment (and divestment) ideas for Companies as well as Fund Managers.

• 
  Meet the Team | Mehta Partners LLC - [Cached Version]
  Published on: 10/5/2009    Last Visited: 10/5/2009  

  Tarun Shah
  
  Tarun Shah, MBA, MP Advisors, is founder of MP Advisors. Tarun Shah brings 22 years of global experience in Corporate Finance and Investment Banking. He significantly influenced the evolution of cross border M&A activities in the pharmaceutical industry in recent years, having conceptualized some of the important transactions as the major companies across the world accelerate their efforts to create new business models in synchronization with the changing times. Tarun has spotted novel investment (and divestment) ideas for Companies as well as Fund Managers.

• 
  Noida Community Portal - NoidaScoop.com || Israeli... - [Cached Version]
  Published on: 5/13/2005    Last Visited: 6/20/2006  

  "Teva has grown mainly through acquisitions," says Tarun Shah, analyst at Mehta Partners' Indian arm.

• 
  People and Partners - [Cached Version]
  Published on: 3/5/2009    Last Visited: 3/5/2009  

  Tarun Shah, Head (Asia), Mehta Partners

Page:  1 2